EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case–control study

BACKGROUND AND OBJECTIVES: Data on the clinical efficacy of EUS-guided ablation using the HybridTherm-Probe (EUS-HTP) in locally advanced pancreatic ductal adenocarcinoma (LA-PDAC) are lacking. The aim of the study was to assess the impact of EUS-HTP added to chemotherapy (CT) on overall survival (O...

Descripción completa

Detalles Bibliográficos
Autores principales: Testoni, Sabrina Gloria Giulia, Petrone, Maria Chiara, Reni, Michele, Di Serio, Clelia, Rancoita, Paola Maria, Rossi, Gemma, Balzano, Gianpaolo, Linzenbold, Walter, Enderle, Markus, Della-Torre, Emanuel, De Cobelli, Francesco, Falconi, Massimo, Capurso, Gabriele, Arcidiacono, Paolo Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688129/
https://www.ncbi.nlm.nih.gov/pubmed/36255026
http://dx.doi.org/10.4103/EUS-D-21-00200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688129/
https://www.ncbi.nlm.nih.gov/pubmed/36255026
http://dx.doi.org/10.4103/EUS-D-21-00200

Ejemplares similares